Who this product is not intended for
As is standard for supplements, pregnant and breastfeeding women and children are excluded. The reason is missing data for those groups rather than a demonstrated risk. Anyone with a known allergy to a component is also excluded.
If you have a chronic condition or take medicines long term, clear the product with a doctor or pharmacist first. That applies particularly to anticoagulants.
The most important known interaction
For glucosamine a possible influence on coumarin anticoagulants is described, in Europe mainly phenprocoumon. Changes in the INR value after additional intake have been reported.
The evidence rests largely on case reports. For a medicine dosed individually by laboratory values, that suspicion is enough to justify clear caution: do not start without consulting, and arrange closer monitoring in the first weeks.
Everyday tolerability
Occasional digestive discomfort, fullness or bloating is reported for products in this category, mostly in the first days. Moving the intake to a meal often helps.
If skin reactions, breathing difficulty or swelling occur, stop immediately and seek medical help. That applies regardless of how unlikely a reaction seems.
When medical assessment comes first
Sudden severe joint pain, swelling with redness and heat, a locked joint, fever together with joint symptoms, or symptoms after a fall all belong in a medical consultation.
In each of these situations a supplement is not a sensible first step. It replaces neither diagnosis nor treatment and should not delay a necessary assessment.